Article
Targeting NAT10 Activates Tumor-Intrinsic Immunity and Suppresses Tumor Progression in Head and Neck Squamous Cell Carcinoma
2026-06-19
Abstract excerpt
<h4>ABSTRACT</h4> Head and neck squamous cell carcinoma (HNSCC) remain a major clinical challenge due to its high heterogeneity and limited therapeutic response, resulting in a 5-year overall survival rate of only ∼50%. Identifying molecular pathways that drive tumor progression while suppressing anti-tumor immunity is therefore critical for developing more effective therapies. N-acetyltransferase 10 (NAT10) is t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2f68ae48-4302-5c78-9af2-f147e47dbd44
- DOI
- 10.64898/2026.06.17.732930
